Apolipoprotein E (APOE) Peptide
APOE
Reactivity: Mammalian
Host: Synthetic
BP, IHC, WB
Catalog No. ABIN940102
Quick Overview for Apolipoprotein E (APOE) Peptide (ABIN940102)
Target
APOE
(Apolipoprotein E (APOE))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Peptide Type
- Synthetic
-
Sequence
- KVLWAALLVT FLAGCQAKVE QAVETEPEPE LRQQTEWQSG QRWELALGRF
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of APOE antibody,
Alternative Names: ApoE control peptide, ApoE antibody Blocking Peptide, Anti-ApoE Blocking Peptide, Apolipoprotein E Blocking Peptide, AD2 Blocking Peptide, MGC1571 Blocking Peptide, apoprotein Blocking Peptide
-
-
Apolipoprotein E (APOE) peptide
APOE Reactivity: Human Host: Synthetic BP, Imm
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- APOE (Apolipoprotein E (APOE))
-
Background
- Chylomicron remnants and very low density lipoprotein (VLDL) remnants are rapidly removed from the circulation by receptor-mediated endocytosis in the liver. Apolipoprotein E, a main apoprotein of the chylomicron, binds to a specific receptor on liver cells and peripheral cells. ApoE is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. Defects in apolipoprotein E result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants.
-
Molecular Weight
- 34 kDa
Target
-
You are here:
